GM-2505 is a short-acting 5-HT 2A receptor agonist/5-HT releaser that is being developed for the treatment of depression and anxiety, and the augmentation of psychotherapy. Like classic ...

Depression, or major depressive disorder ... on the systems in the brain that use the neurotransmitter serotonin (or 5-HT).